It is interesting to note that while KRAS and EMT pathways that result in aggressive tumor biology are enriched in the GR-high group, immune pathways IL2 and apoptosis are also enriched, which may play a role in influencing overall survival. The gene discussed is KRAS; the disease is neoplasm.